Assessment of soluble immune mediators as potential biomarkers during immune checkpoint inhibitor therapy.

Matsuo, Norikazu; Azuma, Koichi; Sasada, Tetsuro.

Afiliação

Matsuo N; Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan.
Azuma K; Cancer Vaccine Center, Kanagawa Cancer Center Research Institute, Yokohama, Kanagawa, Japan.
Sasada T; Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan.

Oncotarget ; 10(20): 1866-1867, 2019 Mar 08.

Article em En | MEDLINE | ID: mdl-30956767